伯氏疟原虫
病毒学
生物
免疫学
免疫
表位
CD8型
疟疾
细胞毒性T细胞
免疫系统
疟原虫(生命周期)
免疫
夏巴迪疟原虫
恶性疟原虫
抗原
细胞免疫
dna疫苗
减毒疫苗
获得性免疫系统
免疫原性
寄生虫血症
作者
Sahaana A. Arumugam,Mariah Hassert,Blandine M. D. Franke-Fayard,John T. Harty
标识
DOI:10.1093/jimmun/vkag314
摘要
Abstract Plasmodium infections and subsequent malaria disease remain a global health scourge. Liver-resident and circulating memory CD8 T cells elicited by whole parasite vaccines such as genetically or radiation-attenuated sporozoites can provide potent immunity to Plasmodium infection and prevent the development of the symptomatic blood stage of infection in humans, nonhuman primates, and mice. However, this requires multiple, large doses of attenuated sporozoites, posing numerous logistical challenges. To partially address these logistical challenges, here, we prime CB6F1 mice with a human weight–normalized, subprotective single dose of genetically or radiation-attenuated Plasmodium berghei sporozoites to elicit liver-resident and circulating memory T cells prior to boosting with a novel lipid nanoparticle mRNA vaccine encoding multiple CD8 T-cell epitopes from liver-stage proteins. We show that boosting primed mice with this mRNA vaccine engenders sterilizing immunity against sporozoite challenge by generating a robust liver-stage–specific CD8 T-cell response when administered intravascularly or intramuscularly. Thus, combining a single, dose-sparing attenuated sporozoite immunization with a multi-epitope translationally relevant mRNA vaccine can engender protective immunity against P. berghei sporozoite challenge via the generation of a potent circulating and resident memory liver CD8 T-cell response. Minimizing the number of attenuated sporozoite doses required to prime CD8 T cells with a full complement of liver-stage malaria–specific epitopes effectively mitigates some logistical challenges associated with attenuated sporozoite vaccination.
科研通智能强力驱动
Strongly Powered by AbleSci AI